Phase I Clinical Study of GB222 to Evaluate the Safety, Tolerability and PK Profiles.
Clinical trial NCT04178057 · UNKNOWN
Trial details
- NCT number
- NCT04178057
- Sponsor
- Genor Biopharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-16
- Primary completion
- 2020-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.